Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
See Latest ArticlesPrescriber Fidelity to a Medication Management Evidence-Based Practice in the Treatment of Schizophrenia
Psychiatric Services, 07/02/09
Howard PB et al. - Implementation and monitoring of MedMAP were feasible in these community mental health settings. Additional implementation projects are crucial for advancing evidence-based practice in clinical settings.
Methods- This three-year longitudinal intervention study implemented MedMAP in six community mental health centers in Kentucky.
- Nine psychiatrists and five advanced practice psychiatric nurses with prescriptive authority participated in the study.
- Prescribers were trained in the use of MedMAP about one month before implementation, and MedMAP principles were reinforced throughout the study.
- Four posttraining assessments were conducted at each site at approximately four-month intervals over a period of 30 months.
- An 18-item scale was used to assess baseline and posttraining prescriber fidelity over a period of 30 months in 900 randomly selected medical records.
- Average fidelity scores improved significantly over baseline at each of the four postimplementation fidelity assessments.
- Training effects were most evident at the second posttraining fidelity assessment, but effects persisted over the course of the study.
- There was considerable variability in scores across items both at baseline and subsequently.
- Posttraining improvement was greatest in patient education, documentation of illness and medication history, and simplification of medication regimen.
Today in Child/Adolescent Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
A Double-Blind, Randomized, Placebo-Controlled Study of Fixed-Dose Aripiprazole in Children and Adolescents With Autistic Disorder
Journal of the American Academy of Child and Adolescent Psychiatry, 10/06/09
How adolescents who cut themselves differ from those who take overdoses
European Child and Adolescent Psychiatry, 10/05/09
Sponsor
Article Search
Sponsor
Sponsor